Dyslipidemia: End Stage Renal Disease and Hemodialysis
The Internet Journal of Nephrology · 2009 · 5 (1)
DOI: 10.5580/169c ↗At a glance
Journal article in The Internet Journal of Nephrology, 2009. Cited 1 times so far (Crossref).
Abstract (original language)
Chronic renal failure (CRF) is a pro-oxidant state and the degree of intracellular and extracellular oxidative stress is related to the severity of renal failure. The present study was taken up to evaluate Dyslipidemia in patients undergoing hemodialysis session. In our study, the hemodialysis patients were found to have Dyslipidemia as evidenced by HD can moderately attenuate the renal dyslipidemia. Accumulation of atherogenic lipoproteins could also play a role in the development of atherosclerotic complications in HD patients. This Dyslipidemia plays an important role in the development of atherosclerosis in hemodialysis
Cite
APA
(2009). Dyslipidemia: End Stage Renal Disease and Hemodialysis. The Internet Journal of Nephrology. https://doi.org/10.5580/169c
Vancouver
Dyslipidemia: End Stage Renal Disease and Hemodialysis. The Internet Journal of Nephrology. 2009. doi:10.5580/169c
BibTeX
@article{euvimed2009,
title = {Dyslipidemia: End Stage Renal Disease and Hemodialysis},
journal = {The Internet Journal of Nephrology},
year = {2009},
doi = {10.5580/169c}
}
EUVIMED